| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| DSP Nifty Healthcare Index Fund (G) Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.11 |
| Equity |
99.17 |
| Trep |
0.94 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
50.38% |
| Top 10 Holdings |
76.20% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
78.78 |
| Healthcare |
20.39 |
| Cash |
0.83 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.10 |
| PE Ratio |
36.38 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
19.29 |
| Dr Reddys Laboratories Limited |
7.93 |
| Apollo Hospitals Enterprise Limited |
7.91 |
| DIVI LABORATORIES LTD |
7.83 |
| Max Healthcare Institute Limited |
7.42 |
| Cipla Limited |
7.14 |
| Lupin Limited |
5.82 |
| Torrent Pharmaceuticals Limited |
4.57 |
| Fortis Health Care Ltd |
4.29 |
| Laurus Labs Limited |
4.00 |
| Aurobindo Pharma Limited |
3.78 |
| Glenmark Pharmaceuticals Limited |
3.33 |
| Alkem Laboratories Limited |
3.22 |
| Biocon Limited |
2.67 |
| Mankind Pharma Limited |
2.35 |
| IPCA Laboratories Limited |
2.31 |
| Zydus Lifesciences Limited |
2.26 |
| Abbott India Limited |
1.40 |
| TREPS / Reverse Repo Investments |
0.94 |
| Piramal Pharma Limited |
0.88 |
| Syngene International Limited |
0.77 |
| Net Receivables/Payables |
-0.11 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|